These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 9069536)

  • 1. In-vitro antifungal susceptibility of clinical and environmental Fusarium spp. strains.
    Pujol I; Guarro J; Gené J; Sala J
    J Antimicrob Chemother; 1997 Feb; 39(2):163-7. PubMed ID: 9069536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antifungal susceptibility of 44 clinical isolates of Fusarium species determined by using a broth microdilution method.
    Reuben A; Anaissie E; Nelson PE; Hashem R; Legrand C; Ho DH; Bodey GP
    Antimicrob Agents Chemother; 1989 Sep; 33(9):1647-9. PubMed ID: 2817867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro sensitivity of medically significant Fusarium species to various antimycotics.
    Sekhon AS; Padhye AA; Garg AK; Ahmad H; Moledina N
    Chemotherapy; 1994; 40(4):239-44. PubMed ID: 8082411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergysm of voriconazole or itraconazole with other antifungal agents against species of Fusarium.
    Spader TB; Venturini TP; Rossato L; Denardi LB; Cavalheiro PB; Botton SA; Santurio JM; Alves SH
    Rev Iberoam Micol; 2013; 30(3):200-4. PubMed ID: 23402831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility of clinical isolates of Fusarium to antifungal drugs.
    Speeleveld E; Gordts B; Van Landuyt HW; De Vroey C; Raes-Wuytack C
    Mycoses; 1996; 39(1-2):37-40. PubMed ID: 8786755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular and MALDI-ToF MS differentiation and antifungal susceptibility of prevalent clinical Fusarium species in China.
    Song Y; Liu X; Yang Z; Meng X; Xue R; Yu J; Al-Hatmi AMS; de Hoog GS; Li R
    Mycoses; 2021 Oct; 64(10):1261-1271. PubMed ID: 34173979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Molecular identification and in vitro susceptibility of Fusarium from fungal keratitis in central China].
    Sun S; Lyu Q; Han L; Ma Q; Hu H; He S; Tao S; Zhang J; Zhang H; Wang L
    Zhonghua Yan Ke Za Zhi; 2015 Sep; 51(9):660-7. PubMed ID: 26693650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. International Evaluation of MIC Distributions and Epidemiological Cutoff Value (ECV) Definitions for Fusarium Species Identified by Molecular Methods for the CLSI Broth Microdilution Method.
    Espinel-Ingroff A; Colombo AL; Cordoba S; Dufresne PJ; Fuller J; Ghannoum M; Gonzalez GM; Guarro J; Kidd SE; Meis JF; Melhem TM; Pelaez T; Pfaller MA; Szeszs MW; Takahaschi JP; Tortorano AM; Wiederhold NP; Turnidge J
    Antimicrob Agents Chemother; 2016 Feb; 60(2):1079-84. PubMed ID: 26643334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Detection of virulence factors and antifungal susceptibilities of Fusarium strains isolated from keratitis cases].
    Çuhadar T; Karabıçak N; Özdil T; Özgür D; Otağ F; Hızel K; Kalkancı A
    Mikrobiyol Bul; 2018 Jul; 52(3):247-258. PubMed ID: 30156511
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Oliveira Dos Santos C; Kolwijck E; van der Lee HA; Tehupeiory-Kooreman MC; Al-Hatmi AMS; Matayan E; Burton MJ; Eggink CA; Verweij PE
    Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31182529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antifungal susceptibility profile of clinical Fusarium spp. isolates identified by molecular methods.
    Alastruey-Izquierdo A; Cuenca-Estrella M; Monzón A; Mellado E; Rodríguez-Tudela JL
    J Antimicrob Chemother; 2008 Apr; 61(4):805-9. PubMed ID: 18263569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro interactions of antifungal agents against clinical isolates of Fusarium spp.
    Córdoba S; Rodero L; Vivot W; Abrantes R; Davel G; Vitale RG
    Int J Antimicrob Agents; 2008 Feb; 31(2):171-4. PubMed ID: 18054469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-centre evaluation of the Etest method for antifungal drug susceptibility testing of Candida spp. and Cryptococcus neoformans. BSAC Working Party on Antifungal Chemotherapy.
    Warnock DW; Johnson EM; Rogers TR
    J Antimicrob Chemother; 1998 Sep; 42(3):321-31. PubMed ID: 9786472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effects of antimicrobial agents against Fusarium species.
    Kawakami H; Inuzuka H; Hori N; Takahashi N; Ishida K; Mochizuki K; Ohkusu K; Muraosa Y; Watanabe A; Kamei K
    Med Mycol; 2015 Aug; 53(6):603-11. PubMed ID: 25841054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fusarium keratitis in South India: causative agents, their antifungal susceptibilities and a rapid identification method for the Fusarium solani species complex.
    Homa M; Shobana CS; Singh YR; Manikandan P; Selvam KP; Kredics L; Narendran V; Vágvölgyi C; Galgóczy L
    Mycoses; 2013 Sep; 56(5):501-11. PubMed ID: 23437826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-vitro antifungal susceptibilities of Basidiobolus and Conidiobolus spp. strains.
    Guarro J; Aguilar C; Pujol I
    J Antimicrob Chemother; 1999 Oct; 44(4):557-60. PubMed ID: 10588321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro susceptibility patterns of Aspergillus and Fusarium species isolated from equine ulcerative keratomycosis cases in the midwestern and southern United States with inclusion of the new antifungal agent voriconazole.
    Pearce JW; Giuliano EA; Moore CP
    Vet Ophthalmol; 2009; 12(5):318-24. PubMed ID: 19751493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro interactions between amphotericin B and other antifungal agents and rifampin against Fusarium spp.
    Spader TB; Venturini TP; Cavalheiro AS; Mahl CD; Mario DN; Lara VM; Santurio J; Alves SH
    Mycoses; 2011 Mar; 54(2):131-6. PubMed ID: 19780977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of in vitro susceptibility of ocular Fusarium spp. isolates from keratitis cases and comparison of Clinical and Laboratory Standards Institute M38-A2 and E test methods.
    Iqbal NJ; Boey A; Park BJ; Brandt ME
    Diagn Microbiol Infect Dis; 2008 Nov; 62(3):348-50. PubMed ID: 18707841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro evaluation of combination antifungal activity against Fusarium species isolated from ocular tissues of keratomycosis patients.
    Li L; Wang Z; Li R; Luo S; Sun X
    Am J Ophthalmol; 2008 Nov; 146(5):724-8. PubMed ID: 18707669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.